Cell and Gene Manufacturing and Logistics

  1. Flexible From Head To Toe: One Bioprocess Controller For All Your Needs 6/10/2026

    Flexible bioprocess control enables seamless transitions from development to scale, combining automation, intuitive operation, and precise environmental management to improve efficiency, reproducibility, and adaptability.

  2. You Develop. We Support. Discover Our Bioprocess Service Offerings. 6/10/2026

    Advancing a bioprocess requires more than internal resources alone. Flexible service support helps bridge expertise and capacity gaps, streamline scale-up, and reduce risk—allowing teams to move with greater speed and confidence.

  3. iPSC Aggregate Culture In Bioreactors Equipped With 8-Blade Impellers 6/10/2026

    Controlled aggregation, oxygen management, and scalable workflows drive consistent iPSC expansion. Parallelized systems and precise parameter control improve reproducibility for faster optimization and confident transitions.

  4. Upstream Bioprocess Equipment For Commercial Manufacturing 6/10/2026

    Modern bioprocessing depends on adaptable, precise equipment that supports scalability and consistency. Discover how to streamline workflows, reduce risk, and maintain control across up- and downstream operations.

  5. Single-Use Bioreactors For Cell Culture And Fermentation 6/10/2026

    Scaling bioprocesses requires consistency and control. Modern single-use systems support reliable tech transfer and simplify workflows, helping teams accelerate development with a strong, reproducible performance.

  6. Efficient Monitoring Of Escherichia Coli Feeding Strategies 6/10/2026

    Consistent, contamination-free sampling is critical for reliable bioprocess data. Automation enables frequent, hands-free collection, improving efficiency and insight while reducing manual workload.

  7. Best Practices For Medication Barcoding In Clinical Trials 6/10/2026

    Investigational products present a distinctly high-risk environment for labeling and barcoding. Explore best practices for barcoding solutions that allow for improved medication safety in clinical trials.

  8. The AI Advantage For Regulated Manufacturing 6/10/2026

    Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.

  9. Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers 6/9/2026

    This is episode 3 of our in vivo-focused special series of Cell & Gene: The Podcast. Here, Ascidian Therapeutics' Founder, President, and CEO Mike Ehlers, M.D., Ph.D., explains how the company is advancing a new class of genetic medicines built on RNA exon editing to durably correct disease at the transcript level without permanently altering DNA.

  10. Improved Methods For CRISPR-Cas9 Homology-Directed Repair 6/9/2026

    Precise genome editing depends on improving HDR efficiency. Learn how guide selection, template design, homology arm optimization, and delivery strategies work together to drive higher-fidelity edits.